Mike Bishop
About Mike Bishop
Mike Bishop serves as the Interim Director of Med Chem, bringing over 25 years of experience in advancing drug programs at GSK and with biotech start-ups.
Mike Bishop - Interim Director of Med Chem
Mike Bishop currently holds the position of Interim Director of Med Chem. With a critical leadership role, he brings over 25 years of experience to his work, navigating complex drug programs and leading scientific endeavors. His extensive background underscores his capability to oversee medicinal chemistry projects effectively. This role involves significant responsibilities in advancing drug discovery initiatives, managing teams, and ensuring the progression of pharmaceutical innovations.
Mike Bishop's Experience in Advancing Drug Programs at GSK
Throughout his career, Mike Bishop has spent a substantial amount of time at GlaxoSmithKline (GSK), where he has been instrumental in advancing various drug programs. His tenure at GSK allowed him to develop a deep understanding of the pharmaceutical industry's drug development processes, from initial discovery stages to late-stage clinical trials. His work has contributed to the development of several therapeutic treatments, enhancing healthcare outcomes.
Mike Bishop's Role with Biotech Start-up Teams
In addition to his experience with GSK, Mike Bishop has collaborated extensively with biotech start-up teams. His involvement with these teams highlights his adaptability and expertise in a dynamic, entrepreneurial environment. Working alongside these innovative groups, Mike has played a crucial role in early-stage biotech initiatives, helping to navigate the complexities of bringing new drug candidates from concept to reality. His contributions have been pivotal in supporting start-ups through critical developmental phases.